Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
ALVO: Alvotech Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
ALVO
The Story
ALVO
Loading chart data...
Current State
Balance holding
The verdict
Good business
Mixed
Revenue growth
+435.6% / yr
Operating margin
13.8%
ROIC
-11.7%
Financially safe
Stretched
Debt / equity
-5.16×
Interest coverage
0.5×
Current ratio
1.76×
Alvotech
ALVO
NASDAQ Global Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Alvotech
ALVO
NASDAQ
·
USD
·
Closed
$4.12
+15.41%
$4.12
+$0.55 (15.41%)
52W Range
19th
pctl
Volume
2.14×
avg
Mkt Cap
1.39B
USD
P/E
-14.5
TTM
Div Yield
–
ann
52W Range
19th
pctl
Volume
2.14×
avg
Market Cap
1.39B
USD
P/E Ratio
-14.5
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings